Abstract
We assessed white matter (WM) atrophy in multiple sclerosis (MS) both cross-sectionally and longitudinally with advanced DWI-techniques and explored whether these measures would better explain clinical and cognitive outcomes in comparison with conventionally used metrics.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
